Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
AssigneeResearch Foundation of CUNY, Hunter College
InventorMarie T. Filbin
Life of this patent
Estimating the term…
Loading patent…
AssigneeResearch Foundation of CUNY, Hunter College
InventorMarie T. Filbin
Estimating the term…
This invention relates to the novel identification of myelin-associated glycoprotein (“MAG”) as a potent inhibitor of neural regeneration. More particularly, this invention relates to compositions and methods useful for reversing inhibition of neural regeneration in the central and peripheral nervous system. Assays to monitor the effects of MAG on neural regeneration and to identify agents which will block or promote the inhibitory effects of MAG on neural outgrowth are provided. Screening methods for identifying such agents are also provided. This invention also relates to compositions and methods using agents that can reverse the inhibitory effects of MAG on neural regeneration. Methods for regulating and for promoting neural growth or regeneration in the nervous system, methods for treating injuries or damage to nervous tissue or neurons, and methods for treating neural degeneration associated with disorders or diseases, comprising the step of administering at least one of the compositions according to this invention are provided.
A composition which comprises a pharmaceutically acceptable carrier and at least one MAG inhibitor in an amount effective for altering neural growth or regeneration in the nervous system, said MAG inhibitor comprising an altered or a mutated form of MAG characterized by an altered biological activity.
A method for determining whether neurite outgrowth from a particular type of neuron at a particular age is stimulated or inhibited in the presence of an altered or mutated form of MAG which comprises the steps of:
A method for identifying a MAG-dependent neurite growth altering agent for a selected neuronal cell type which comprises the steps of:
A method for identifying a MAG-dependent neurite growth altering agent for a selected neuronal cell type comprising the steps of:
Dependencies are inferred from the claim text.